| Literature DB >> 32802981 |
Abir Sagaama1, Silvia Antonia Brandan2, Takoua Ben Issa1, Noureddine Issaoui1.
Abstract
In the present work, the succinic acid (Entities:
Keywords: ACPS; COVID-19 treatment; KDH; Molecular docking simulation; Pharmaceutical chemistry; Quantum chemical calculation; Theoretical chemistry
Year: 2020 PMID: 32802981 PMCID: PMC7409764 DOI: 10.1016/j.heliyon.2020.e04640
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Figure 1Optimized structures of six studied compounds: Succinic acid (SA); L-pyroglutamic acid (L-PGA); N-phenyl-thioacetamide (N-NPTA); 2-amino-5-chloropyridine hydrogen succinate (ACPS); Epigallocatechine Gallate (EGCG) or KDH; Selenomethionine (SeM).
Calculated total and corrected by ZPVE energies (E), dipole moments (μ) and volumes (V) of six antiviral candidates proposed in gas phase and aqueous solution by using B3LYP/6-311++G∗∗ level of theory.
| B3LYP/6-311++G∗∗ Method | ||||||||
|---|---|---|---|---|---|---|---|---|
| Species | GAS | PCM | ||||||
| E (Hartrees) | E/ZPVE (Hartrees) | μ (D) | V (Å3) | E (Hartrees) | E/ZPVE (Hartrees) | μ (D) | V (Å3) | |
| SA | -457.1214 | -457.0160 | 0.00 | 117.7 | -457.1428 | -457.0152 | 0.53 | 114.4 |
| L-PGA | -475.3499 | -475.2248 | 4.96 | 125.7 | -475.3766 | -475.2227 | 7.64 | 125.2 |
| N-NPTA | -763.3409 | -763.1883 | 4.16 | 160.2 | -763.3536 | -763.1873 | 6.89 | 160.7 |
| ACPS | -1220.4569 | -1220.2546 | 9.48 | 243.7 | -1220.5171 | -1220.2227 | 24.09 | 259.5 |
| KDH | -1677.1395 | -1676.7622 | 3.06 | 425.5 | -1677.1979 | -1676.7601 | 4.48 | 426.3 |
| SeM | -2804.0450 | -2803.8814 | 2.23 | 167.0 | -2804.0664 | -2803.8798 | 3.94 | 166.6 |
Succinic acid (SA); L-pyroglutamic acid (L-PGA); N-phenyl-thioacetamide (N-NPTA); 2-amino-5-chloropyridine hydrogen succinate (ACPS); Epigallocatechine Gallate (EGCG) or KDH; Selenomethionine (SeM).
Figure 2Variations observed in the dipole moment (a) and volume (b) values of six proposed antiviral compounds in gas phase and aqueous solution by using the B3LYP/6-311++G∗∗ method. Succinic acid (SA); L-pyroglutamic acid (L-PGA); N-phenyl-thioacetamide (N-NPTA); 2-amino-5-chloropyridine hydrogen succinate (ACPS); Epigallocatechine Gallate (EGCG) or KDH; Selenomethionine (SeM).
Corrected solvation energies (ΔGC/ZPVE) and uncorrected by ZPVE energies (ΔGC) and, volumes variations (ΔV) of nine species proposed in aqueous solution by using B3LYP/6-311++G∗∗ level of theory.
| Species | ΔGun (kJ/mol) | ΔGne (kJ/mol) | ΔGC (kJ/mol) | ΔV (Å3) | ΔGC/ZPVE (kJ/mol) |
|---|---|---|---|---|---|
| SA | -56.13 | 24.41 | -80.54 | -3.3 | -26.51 |
| L-PGA | -70.03 | 20.02 | -90.05 | -0.5 | -25.53 |
| N-NPTA | -33.31 | 14.04 | -47.35 | 0.5 | -16.66 |
| ACPS | -157.90 | 31.98 | -189.88 | 15.8 | -115.65 |
| KDH | -153.18 | 49.16 | -202.34 | 0.8 | -54.67 |
| SeM | -56.13 | 17.97 | -74.10 | -0.4 | -22.17 |
Succinic acid (SA); L-pyroglutamic acid (L-PGA); N-phenyl-thioacetamide (N-NPTA); 2-amino-5-chloropyridine hydrogen succinate (ACPS); Epigallocatechine Gallate (EGCG) or KDH; Selenomethionine (SeM).
Uncorrected solvation energies by ZPVE energies (ΔGC) and numbers of N–H and O–H groups and N and O atoms present in six antiviral proposed species in aqueous solution by using the hybrid B3LYP/6-311++G∗∗ method.
| Nº | Species | ΔGC | N–H | O–H | O | C=O | N | Total | Groups | Rings |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SA | -80.54 | 2 | 4 | 2 | 8 | ||||
| 2 | L-PGA | -90.05 | 1 | 1 | 3 | 2 | 1 | 8 | R5 | |
| 3 | N-NPTA | -47.35 | 1 | 1 | 1 | 3 | C=S | R6 | ||
| 4 | ACPS | -189.88 | 3 | 1 | 4 | 3 | 2 | 13 | Cl | R6 |
| 5 | KDH | -202.34 | 8 | 10 | 1 | 19 | 4 R6 | |||
| 6 | SeM | -74.10 | 2 | 1 | 2 | 1 | 1 | 7 | Se |
Succinic acid (SA); L-pyroglutamic acid (L-PGA); N-phenyl-thioacetamide (N-NPTA); 2-amino-5-chloropyridine hydrogen succinate (ACPS); Epigallocatechine Gallate (EGCG) or KDH; Selenomethionine (SeM).
Figure 3Total number of acceptor and donors groups of six antiviral candidates as function of corrected solvation energy values calculated in aqueous solution by using B3LYP/6-311++G∗∗ level of theory. Succinic acid (SA); L-pyroglutamic acid (L-PGA); N-phenyl-thioacetamide (N-NPTA); 2-amino-5-chloropyridine hydrogen succinate (ACPS); Epigallocatechine Gallate (EGCG) or KDH; Selenomethionine (SeM).
Uncorrected solvation energies by ZPVE energies (ΔGC) and numbers of N–H and O–H groups and N and O atoms present in ten antiviral species in aqueous solution by using the hybrid B3LYP method.
| Nº | Species | ΔGC | Total Acceptor/donor |
|---|---|---|---|
| 1 | Isothiazolb, | -37,51 | 3 |
| 2 | N-NPTAa | -47,35 | 3 |
| 3 | Chloroquinea | -52,06 | 4 |
| 4 | SeMa | -74,10 | 7 |
| 5 | Niclosamidea | -78,43 | 9 |
| 6 | Zalcitabinec | -78,92 | 10 |
| 7 | SAa | -80,54 | 8 |
| 8 | L-PGAa | -90,05 | 8 |
| 9 | Emtricitabined | -100,88 | 10 |
| 10 | Trifluridinee | -113,85 | 12 |
| 11 | Thymidinef | -116,16 | 12 |
| 12 | Idoxuridineg,# | -124,50 | 12 |
| 13 | Ribavirinh | -141,85 | 15 |
| 14 | Cidofoviri | -169,21 | 15 |
| 15 | ACPSa | -189,88 | 13 |
| 16 | KDHa | -202,34 | 19 |
| 17 | Foscarnetj | -219,64 | 19 |
| 18 | Brincidofoviri | -227,34 | 15 |
aThis work, bFrom Ref [16], cFrom Ref [17], dFrom Ref [20], eFrom Ref [18], fFrom Ref [15, 21], gFrom Ref [19], hFrom Ref [23], iFrom Ref [24], jFrom Ref [22]. #Idoxuridine calculated by using B3LYP/3-21G∗ calculations. aBy using hybrid B3LYP/6-311++G∗∗ method, b-jBy using B3LYP/6-31G∗ method.
Figure 4Total number of acceptor and donors groups of six antiviral candidates as function of corrected solvation energy values calculated in aqueous solution by using B3LYP/6-311++G∗∗ level of theory. Succinic acid (SA); L-pyroglutamic acid (L-PGA); N-phenyl-thioacetamide (N-NPTA); 2-amino-5-chloropyridine hydrogen succinate (ACPS); Epigallocatechine Gallate (EGCG) or KDH; Selenomethionine (SeM).
Calculated HOMO-LUMO, gap values and chemical potential (μ), electronegativity (χ), global hardness (η), global softness (S), global electrophilicity index (ω) and global nucleophilicity index (Ε) of six antiviral proposed compounds by using the hybrid B3LYP level of theory.
| B3LYP/6-311++G∗∗ | ||||||
|---|---|---|---|---|---|---|
| Gas phase | ||||||
| Orbitals | ACPS | KDH | L-PGA | SeM | N-NPTA | SA |
| HOMO | -6.4573 | -6.0273 | -7.1893 | -6.0137 | -5.8804 | -8.0954 |
| LUMO | -2.1715 | -1.3633 | -0.9197 | -0.5633 | -1.6191 | -0.5687 |
| ∣GAP∣ | 4.2858 | 4.6640 | 6.2696 | 5.4504 | 4.2613 | 7.5267 |
| Descriptors | ||||||
| χ | -2.1429 | -2.3320 | -3.1348 | -2.7252 | -2.1307 | -3.7634 |
| μ | -4.3144 | -3.6953 | -4.0545 | -3.2885 | -3.7498 | -4.3321 |
| η | 2.1429 | 2.3320 | 3.1348 | 2.7252 | 2.1307 | 3.7634 |
| 0.2333 | 0.2144 | 0.1595 | 0.1835 | 0.2347 | 0.1329 | |
| ω | 4.3432 | 2.9278 | 2.6220 | 1.9841 | 3.2996 | 2.4933 |
| Ε | -9.2453 | -8.6174 | -12.7100 | -8.9618 | -7.9894 | -16.3030 |
| Aqueous solution | ||||||
| Orbitals | ACPS | KDH | L-PGA | SeM | N-NPTA | SA |
| HOMO | -4,5525 | -6,0709 | -7,0695 | -6,0246 | -5,7144 | -8,0355 |
| LUMO | -3,6246 | -1,3633 | -0,9197 | -0,5742 | -1,5320 | -0,6095 |
| ∣GAP∣ | 0,9279 | 4,7076 | 6,1498 | 5,4504 | 4,1824 | 7,4260 |
| Descriptors | ||||||
| (eV) | ACPS | KDH | L-PGA | SeM | N-NPTA | SA |
| χ | -0.4640 | -2.3538 | -3.0749 | -2.7252 | -2.0912 | -3.7130 |
| μ | -4.0886 | -3.7171 | -3.9946 | -3.2994 | -3.6232 | -4.3225 |
| η | 0.4640 | 2.3538 | 3.0749 | 2.7252 | 2.0912 | 3.7130 |
| 1.0777 | 0.2124 | 0.1626 | 0.1835 | 0.2391 | 0.1347 | |
| ω | 18.0151 | 2.9350 | 2.5947 | 1.9973 | 3.1388 | 2.5160 |
| Ε | -1.8969 | -8.7493 | -12.2830 | -8.9915 | -7.5768 | -16.0494 |
χ = - [E(LUMO)- E(HOMO)]/2; μ = [E(LUMO) + E(HOMO)]/2; η = [E(LUMO) - E(HOMO)]/2;S = ½η; ω = μ2/2η; Ε = μ∗η; Succinic acid, SA; L-pyroglutamic acid, L-PGA; N-phenyl-thioacetamide N-NPTA; 2-amino-5-chloropyridine hydrogen succinate, ACPS; Epigallocatechine Gallate (EGCG) KDH; Selenomethionine, SeM.
Calculated gap values of six antiviral proposed compounds in aqueous solution compared with values reported for other antiviral agents in the same medium by using the hybrid B3LYP level of theory.
| Species | GAP (eV) | |
|---|---|---|
| B3LYP Method | ||
| 6-31G∗ | 6-311++G∗∗ | |
| Niclosamide | 3,7225 | |
| Chloroquine | 4,4571 | |
| Isothiazol | 4,507 | |
| Zalcitabine | 5,3595 | |
| Emtricitabine | 4,9336 | |
| Trifluridine | 5,5876 | |
| Thymidine | 5,4748 | |
| Idoxuridine | 5,0162 | |
| Ribavirin | 5,8428 | |
| Cidofovir | 5,2015 | |
| Foscarnet | 4,7387 | |
| Brincidofovir | 5,2987 | |
| ACPS | 0,6777 | 0,9279 |
| KDH | 4,7343 | 4,7076 |
| L-PGA | 4,4472 | 6,1498 |
| SeM | 5,8300 | 5,4504 |
| N-NPTA | 4,2638 | 4,1824 |
| SA | 7,4856 | 7,4260 |
Succinic acid, SA; L-pyroglutamic acid, L-PGA; N-phenyl-thioacetamide N-NPTA; 2-amino-5-chloropyridine hydrogen succinate, ACPS; Epigallocatechine Gallate (EGCG) KDH; Selenomethionine, SeM.
This work.
From Ref [16].
From Ref [17].
From Ref [20].
From Ref [18].
From Ref [15, 21].
From Ref [19].
From Ref [23].
From Ref [24].
From Ref [22].
Idoxuridine calculated by using B3LYP/3-21G∗ calculations.
Figure 5Variations in the gap values for the proposed six species in solution by using the 6-311++G∗∗ basis set with the corresponding observed for twelve antiviral predicted in the same medium at B3LYP/6-31G∗level of theory. Succinic acid, SA; L-pyroglutamic acid, L-PGA; N-phenyl-thioacetamide N-NPTA; 2-amino-5-chloropyridine hydrogen succinate, ACPS; Epigallocatechine Gallate (EGCG) KDH; Selenomethionine, SeM.
Figure 6Variations in the gap values predicted for the proposed six species in aqueous solution by using both B3LYP/6-31G∗ and B3LYP/6-311++G∗∗ levels of theory. Succinic acid, SA; L-pyroglutamic acid, L-PGA; N-phenyl-thioacetamide N-NPTA; 2-amino-5-chloropyridine hydrogen succinate, ACPS; Epigallocatechine Gallate (EGCG) KDH; Selenomethionine, SeM.
Main delocalization energies (in kJ/mol) for the six proposed species in gas and aqueous solution phases by using B3LYP/6-311++G∗∗ calculations.
| B3LYP/6-311++G∗∗ | ||||||||
|---|---|---|---|---|---|---|---|---|
| SA | SeM | N-NPTA | L-PGA | |||||
| Delocalization | Gas | PCM | Gas | PCM | Gas | PCM | Gas | PCM |
| 494.12 | 507.91 | |||||||
| 368.60 | 376.20 | 185.21 | 188.14 | 379.33 | 78.29 | 434.93 | 460.80 | |
| 430.92 | 411.85 | 213.97 | 205.53 | 56.89 | 241.14 | 416.62 | 385.69 | |
| 118.88 | ||||||||
| 1001.40 | ||||||||
| 799.52 | 788.05 | 399.18 | 393.67 | 930.34 | 1947.62 | 851.55 | 846.49 | |
| KDH | ACPS | |||||||
| 217.36 | 277.97 | |||||||
| 8448.11 | 43977.70 | 79.59 | ||||||
| 739.61 | 980.38 | |||||||
| 2860.29 | 604.43 | 425.56 | ||||||
| 5003.46 | 545.61 | 422.18 | ||||||
| 16311.86 | 43977.70 | 2186.6 | 2106.09 | |||||
This work.
Figure 7Molecular graphics of Succinic acid, SA; L-pyroglutamic acid, L-PGA; N-phenyl-thioacetamide N-NPTA; 2-amino-5-chloropyridine hydrogen succinate, ACPS; Epigallocatechine Gallate (EGCG) KDH; Selenomethionine, SeM in aqueous solution showing the geometry of all their bond critical points (BCPs) and ring critical points (RCPs) at the B3LYP/6-311++G∗∗ level of theory.
Figure 8Calculated electrostatic potential surfaces on the molecular surfaces of Succinic acid, SA; L-pyroglutamic acid, L-PGA; N-phenyl-thioacetamide N-NPTA; 2-amino-5-chloropyridine hydrogen succinate, ACPS; Epigallocatechine Gallate (EGCG) KDH; Selenomethionine, SeM in aqueous solution. Color ranges ±0.070 a.u. B3LYP functional with 6–311++G∗∗and 6-31G∗ basis sets. Isodensity value of 0.004.
The binding scores of the docked ligands in COVID-19 active sites by using iGEMDOCK program.
| Ligands | COVID-19 viruses | Interaction energies (kcal/mol) | EH-bond | EVDW | EElectrost |
|---|---|---|---|---|---|
| SA | 6LU7 | -66.94 | -24.62 | -40.00 | -2.31 |
| 6M03 | -62.65 | -29.92 | -30.96 | -1.76 | |
| 6W63 | -63.75 | -17.44 | -40.32 | 5.98 | |
| 7BTF | -67.52 | -24.58 | -37.23 | -5.71 | |
| L-PGA | 6LU7 | -70.98 | -26.75 | -42.75 | -1.48 |
| 6M03 | -72.39 | -27.49 | -44.50 | -0.40 | |
| 6W63 | -81.44 | -33.84 | -46.82 | -0.77 | |
| 7BTF | -73.58 | -17.06 | -54.24 | -2.27 | |
| N-PTA | 6LU7 | -55.68 | -3.5 | -52.18 | 0 |
| 6M03 | -55.39 | -3.5 | -51.89 | 0 | |
| 6W63 | -59.68 | -8.20 | -51.48 | 0 | |
| 7BTF | -74.50 | -9.59 | -64.90 | 0 | |
| ACPS | 6LU7 | -100.70 | -31.64 | -65.02 | -4.03 |
| 6M03 | -76.77 | -30.64 | -46.12 | 0 | |
| 6W63 | -93.68 | -26.70 | -60.11 | -6.86 | |
| 7BTF | -99.01 | -22.93 | -74.02 | -2.04 | |
| KDH | 6LU7 | -135.65 | -37.18 | -98.47 | 0 |
| 6M03 | -121.67 | -41.57 | -80.09 | 0 | |
| 6W63 | -122.12 | -27.79 | -94.33 | 23.36 | |
| 7BTF | -129.13 | -58.71 | -70.42 | 0 | |
| SeM | 6LU7 | -67.76 | -30.09 | -37.67 | 0 |
| 6M03 | -62.86 | -25.34 | -37.51 | 0 | |
| 6W63 | -71.49 | -24.18 | -44.99 | -2.31 | |
| 7BTF | -81.87 | -27.86 | -49.99 | -4.00 |
Autodock binding affinities of the candidate compounds.
| Protein | Binding score (kcal/mol) | |||||
|---|---|---|---|---|---|---|
| SA | L-PGA | NPTA | ACPS | KDH | SeM | |
| 6LU7 | -3.9 | -4.4 | -4.2 | -4.2 | -8.3 | -4.4 |
| 6M03 | -4.2 | -4.5 | -4.8 | -3.8 | -7.4 | -4.7 |
| 6W63 | -4.7 | -4.3 | -4.7 | -4.4 | -10.4 | -4.9 |
| 7BTF | -4.2 | -5.0 | -4.6 | -3.9 | -9.5 | -4.9 |
Figure 9The best poses of SA in 6LU7, 6M03, 6W63 and 7BTF viruses along with 2D visual representation.
Residues-ligand interactions for Succinic acid and the different COVID-19 constructions.
| Virus | Residues | Atoms | Distance (Å) | Category | Type |
|---|---|---|---|---|---|
| 6LU7 | A:SER:144 | O8 | 2.71 | H-bond | Conventional hydrogen bond |
| A:CYS:145 | 2.63 | ||||
| A:GLY:166 | O1 | 3.31 | |||
| 6M03 | A:SER:144 | O1 | 2.64 | H-bond | Conventional hydrogen bond |
| A:CYS:145 | 2.60 | ||||
| A:GLU:166 | O8 | 3.09 | |||
| 6W63 | A:ARG:76 | O1 | 2.15 | H-bond | Conventional hydrogen bond |
| A:VAL:77 | O8 | 1.88 | |||
| 7BTF | A:ARG:305 | O1 | 3.09 | H-bond | Conventional hydrogen bond |
| A:ARG:467 | 3.10 | ||||
| A:ARG:735 | O9 | 2.65 |
Figure 10Non covalent interactions and 3D H-bond surface of SA in 6LU7, 6M03, 6W63 and 7BTF.
Figure 11The best poses of L-PGA in 6LU7, 6M03, 6W63 and 7BTF viruses along with 2D visual representation.
Residues-ligand interactions for L-PGA acid and the different COVID-19 constructions.
| Virus | Residues | Atoms | Distance (Å) | Category | Type |
|---|---|---|---|---|---|
| 6LU7 | A:GLU:166 | O15 | 3.10 | H-bond | Conventional H-bond |
| A:LEU:141 | H3 | 2.05 | |||
| A:SER:144 | O1 | 2.66 | |||
| H3 | 2.37 | ||||
| A:GLU:143 | O1 | 3.17 | |||
| A:CYS:145 | O1 | 2.60 | |||
| A:HIS:172 | O14 | 3.60 | Carbon H-bond | ||
| 6M03 | A:SER:144 | O14 | 2.36 | H-bond | Conventional H-bond |
| H3 | 2.94 | ||||
| A:CYS:145 | O14 | 2.60 | |||
| H16 | 2.99 | ||||
| A:HIS:172 | O1 | 3.47 | Carbon H-bond | ||
| 6W63 | A:GLU:143 | H16 | 2.21 | H-bond | Conventional H-bond |
| A:SER:144 | O14 | 2.26 | |||
| A:CYS:145 | O14 | 1.95 | |||
| A:HIS:172 | O1 | 2.53 | Carbon H-bond | ||
| A:HIS:163 | H16 | 1.91 | Conventional H-bond | ||
| 7BTF | A:ARG:305 | H16 | 2.14 | Other | Unfavourable donor-donor |
| A:ASP:738 | O1 | 3.11 | H-bond | Conventional H-bond | |
| A:ASP:734 | H16 | 2.26 | |||
| A:ASP:736 | H16 | 2.22 | Carbon H-bond | ||
| H16 | 2.73 |
Figure 12Non covalent interactions and 3D H-bond surface of NPTA in 6LU7, 6M03, 6W63 and 7BTF.
Figure 13The best poses of SA in 6LU7, 6M03, 6W63 and NPTA viruses along with 2D visual representation.
Residues-ligand interactions for NPTA and the different COVID-19 constructions.
| Virus | Residues | Atoms | Distance (Å) | Category | Type |
|---|---|---|---|---|---|
| 6LU7 | A:MET:165 | H19 | 2.15 | H-bond | Conventional H-bond |
| N2 | 2.87 | Other | Sulfur-X | ||
| Phenyl ring | 4.46 | Hydrophobic | pi-alkyl | ||
| A:ARG:188 | H19 | 2.73 | H-bond | Conventional H-bond | |
| A:HIS:41 | Phenyl ring | 4.29 | Hydrophobic | pi-pi T-shaped | |
| 6M03 | A:PHE:66 | H19 | 2.65 | H-bond | Conventional H-bond |
| A:VAL:77 | Phenyl ring | 3.58 | H-bond | Pi-donor hydrogen bond | |
| 5.08 | Hydrophobic | pi-alkyl | |||
| A:ARG:76 | 4.16 | pi-alkyl | |||
| 6W63 | A:ASN:142 | S1 | 3.04 | H-bond | Conventional H-bond |
| A:PHE:140 | H19 | 1.96 | |||
| A:GLU:166 | H19 | 2.16 | |||
| A:CYS:145 | Phenyl ring | 5.47 | Other | pi-sulfur | |
| A:LEU:141 | 3.76 | Hydrophobic | Amide-pi stacked | ||
| 7BTF | A:ARG:305 | S1 | 3.29 | H-bond | Conventional H-bond |
| A:CYS:730 | H19 | 2.39 | H-bond | Conventional H-bond | |
| Phenyl ring | 5.08 | Hydrophobic | pi-alkyl | ||
| A:ASN:734 | H19 | 2.27 | H-bond | Conventional H-bond | |
| A:ASP:736 | H19 | 2.90 | H-bond | Conventional H-bond | |
| A:VAL:737 | Phenyl ring | 3.80 | Hydrophobic | pi-sigma | |
| A:PHE:471 | 5.05 | pi-pi T-shaped |
Figure 14Non covalent interactions and 3D H-bond surface of NPTA in 6LU7, 6M03, 6W63 and 7BTF.
Figure 15The best docked poses of our ligand in 6LU7, 6M03, 6W63 and 7BTF.
Residues-ligand interactions for ACPS and the different COVID-19 constructions.
| Virus | Residues | Atoms | Distance (Å) | Category | Type |
|---|---|---|---|---|---|
| 6LU7 | A:GLY:143 | O16 | 2.66 | H-bond | Conventional H-bond |
| A:SER:144 | O18 | 3.00 | |||
| A:CYS:145 | O18 | 2.59 | |||
| O15 | 3.13 | ||||
| A:HIS:164 | H13 | 2.39 | |||
| A:CYS:145 | H27 | 2.94 | |||
| A:MET:165 | 2-amino-5-chloropyridinium ring | 5.91 | Other | pi-sulfur | |
| A:HIS:41 | 3.92 | Hydrophobic | pi-pi stacked | ||
| Cl1 | 5.06 | Alkyl | |||
| A:MET:49 | Cl1 | 3.91 | pi-alkyl | ||
| 2-amino-5-chloropyridinium ring | 4.88 | ||||
| 6M03 | A:THR:25 | H13 | 2.22 | H-bond | Conventional H-bond |
| H27 | 2.73 | ||||
| A:THR:24 | H27 | 2.84 | |||
| A:LYS:61 | Cl1 | 2.62 | Carbon H-bond | ||
| A:VAL:42 | H11 | 1.49 | |||
| A:THR:24 | 2-amino-5-chloropyridinium ring | 3.93 | pi-donor H-bond | ||
| A:CYS:22 | 5.11 | Other | pi-sulfur | ||
| A:ILE:43 | Cl1 | 4.77 | Hydrophobic | Alkyl | |
| A:LYS:61 | Cl1 | 4.46 | |||
| 6W63 | A:PHE:66 | H13 | 2.23 | H-bond | Conventional H-bond |
| A:ASN:63 | H27 | 2.39 | |||
| A:HIS:64 | O15 | 2.55 | Carbon H-bond | ||
| O18 | 2.92 | ||||
| A:LEU:67 | 2-amino-5-chloropyridinium ring | 2.75 | Hydrophobic | pi-sigma | |
| 7BTF | A:SER:592 | O17 | 3.11 | H-bond | Conventional H-bond |
| A:ASN:600 | O16 | 2.86 | |||
| A:MET:601 | Cl1 | 5.27 | Hydrophobic | Alkyl | |
| 2-amino-5-chloropyridinium ring | 4.26 | pi-alkyl | |||
| A:ARG:583 | 4.15 | ||||
| A:VAL:588 | 5.24 |
Figure 16Non covalent interactions and 3D H-bond surface of ACPS in 6LU7, 6M03, 6W63 and 7BTF.
Figure 17The best poses of KDH in 6LU7, 6M03, 6W63 and 7BTF viruses along with 2D visual representation.
Residues-ligand interactions for KDH and the different COVID-19 constructions.
| Virus | Residues | Atoms | Distance (Å) | Category | Type |
|---|---|---|---|---|---|
| 6LU7 | A:GLN:189 | O1 | 2.67 | H-bond | Conventional H-bond |
| A:PHE:140 | H48 | 2.23 | |||
| A:MET:165 | H50 | 2.64 | |||
| Phenyl ring (C32,C20) | 5.04 | Hydrophobic | pi-alkyl | ||
| A:GLN:189 | O31 | 2.98 | H-bond | Carbon H-bond | |
| A:CYS:145 | Phenyl ring (C14,C13) | 4.88 | Other | pi-sulfur | |
| Phenyl ring (C9,C16) | 4.85 | Hydrophobic | Alkyl | ||
| A:HIS:41 | Phenyl ring (C32,C20) | 5.10 | pi-pi T shaped | ||
| 6M03 | A:GLU:192 | O33 | 2.60 | H-bond | Conventional H-bond |
| A:SER:46 | H42 | 2.94 | |||
| A:CYS:145 | H41 | 2.70 | |||
| Phenyl ring (C9,C16) | 5.06 | Hydrophobic | Alkyl | ||
| A:GLY:166 | H49 | 1.60 | H-bond | Conventional H-bond | |
| A:ARG:188 | H51 | 1.82 | |||
| A:GLN:189 | Phenyl ring (C32,C20) | 2.91 | pi-donor H-bond | ||
| A:MET:49 | Phenyl ring (C7,C2) | 5.27 | Hydrophobic | pi-alkyl | |
| A:MET:165 | Phenyl ring (C32,C20) | 4.26 | |||
| 6W63 | A:GLN:189 | O27 | 2.91 | H-bond | Conventional H-bond |
| A:THR:190 | O4 | 2.34 | |||
| O6 | 3.14 | ||||
| A:GLN:192 | O1 | 2.28 | |||
| O4 | 2.16 | ||||
| A:ASN:142 | O24 | 3.07 | |||
| A:ASP:187 | O31 | 2.79 | |||
| A:CYS:44 | O33 | 3.10 | |||
| A:HIS:41 | O29 | 2.53 | Carbon H-bond | ||
| Phenyl ring (C32,C20) | 4.95 | Other | pi-pi Tshaped | ||
| A:MET:165 | Phenyl ring (C7,C2) | 5.45 | Hydrophobic | pi-sulfur | |
| A:PRO:168 | 5.20 | pi-alkyl | |||
| A:MET:49 | Phenyl ring (C32,C20) | 5.41 | |||
| 7BTF | A:ARG:553 | O27 | 3.16 | H-bond | Conventional H-bond |
| Phenyl ring (C7,C2) | 3.59 | H-bond + electrostatic | pi-cation, pi donor H-bond | ||
| A:ARG:555 | O27 | 2.79 | H-bond | Conventional H-bond | |
| A:CYS:622 | O29 | 2.60 | |||
| A:THR:687 | O23 | 3.23 | |||
| A:ALA:554 | O6 | 1.70 | |||
| A:TYR:619 | H50 | 2.32 | |||
| A:ARG:624 | Phenyl ring (C7,C2) | 3.87 | H-bond + electrostatic | pi-cation, pi donor H-bond | |
| A:THR:556 | 3.75 | Hydrophobic | pi-sigma |
Figure 18Non covalent interactions and 3D H-bond surface of KDH in 6LU7, 6M03, 6W63 and 7BTF.
Figure 19The best poses of SeM in 6LU7, 6M03, 6W63 and 7BTF viruses along with 2D visual representation.
Residues-ligand interactions for SeM and the different COVID-19 constructions.
| Virus | Residues | Atoms | Distance (Å) | Category | Type |
|---|---|---|---|---|---|
| 6LU7 | A:THR:24 | O4 | 2.85 | H-bond | Conventional H-bond |
| A:THR:25 | 2.59 | ||||
| H10 | 2.70 | ||||
| A:CYS:44 | 2.04 | ||||
| A:CYS:22 | H11 | 1.94 | |||
| A:VAL:42 | 2.84 | ||||
| A:LEU:57 | C9 | 4.45 | Hydrophobic | Alkyl | |
| 6M03 | A:THR:24 | O4 | 2.84 | H-bond | Conventional H-bond |
| O5 | 2.66 | ||||
| A:THR:25 | O4 | 3.12 | |||
| A:CYS:44 | H10 | 2.20 | |||
| A:CYS:22 | H11 | 1.88 | |||
| A:VAL:42 | H10 | 2.68 | |||
| A:LEU:57 | C9 | 3.96 | Hydrophobic | Alkyl | |
| 6W63 | A:SER:144 | O4 | 2.91 | H-bond | Conventional H-bond |
| A:CYS:145 | 2.51 | ||||
| A:LEU:141 | H10 | 2.18 | |||
| A:HIS:163 | H11 | 2.09 | |||
| O4 | 3.02 | Carbon H-bond | |||
| 7BTF | A:ARG:305 | O5 | 3.09 | H-bond | Conventional H-bond |
| A:ARG:467 | 3.11 | ||||
| A:LEU:731 | H10 | 2.12 | |||
| A:ARG:733 | 2.70 | ||||
| A:ARG:735 | H13 | 2.46 | |||
| 2.36 | Carbon H-bond | ||||
| A:ASN:734 | 2.96 | ||||
| A:VAL:737 | C9 | 4.51 | Hydrophobic | Alkyl | |
| A:VAL:742 | 4.90 | ||||
| A:PHE:471 | 4.62 | pi-alkyl |
Figure 20Non covalent interactions and 3D H-bond surface of SeM in 6LU7, 6M03, 6W63 and 7BTF.